Kyverna Therapeutics (KYTX) Amortizatization of Intangibles (2023 - 2026)

Kyverna Therapeutics (KYTX) has 4 years of Amortizatization of Intangibles data on file, last reported at $730000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 65.4% year-over-year to $730000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (down 41.98% YoY) and the FY2025 annual result came in at $6.9 million, down 10.13% from the prior year.
• Amortizatization of Intangibles eased to $730000.0 in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.9 million in Q3 2024 to a low of -$8000.0 in Q2 2023.
• A 4-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles jumped 28287.5% — and 2026, when it plunged 65.4%.
• Tracing KYTX's Amortizatization of Intangibles over 4 years: stood at $605000.0 in 2023, then jumped by 269.59% to $2.2 million in 2024, then slumped by 38.82% to $1.4 million in 2025, then plunged by 46.64% to $730000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $730000.0 (Q1 2026), $1.4 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.